Boardroom Governance Newsletter

Boardroom Governance Newsletter

Share this post

Boardroom Governance Newsletter
Boardroom Governance Newsletter
Light at the End of the Tunnel.

Light at the End of the Tunnel.

Boardroom Governance Newsletter #6 | November 2020 Edition

Evan Epstein's avatar
Evan Epstein
Nov 17, 2020
∙ Paid

Share this post

Boardroom Governance Newsletter
Boardroom Governance Newsletter
Light at the End of the Tunnel.
Share

There is a lot of relief around the world with the positive news on COVID-19 vaccines. The Pfizer/BioNTech vaccine was found to be more than 90% effective and Moderna’s 94.5% effective. Check out this profile of Ugur Sahin and Özlem Türeci, the husband-and-wife team that founded BioNTech, the German biotech company that partnered with Pfizer to develop the vaccine. Their work and friendship with Albert Bourla, the Greek CEO of U.S.-based Pfizer, is a very inspiring story of immigration, market economy and open society. Similarly, Moderna’s co-founders and CEO are also immigrants: Noubar Afeyan (Armenian from Lebanon, via Canada), Derrick Rossi (Canada) and Stéphane Bancel (France). Definitely a win for immigrants!

Despite these good news (there are also 320 other vaccines in development) the distribution of these vaccines to the general public will take time. So better keep your masks on, as we may have a tough winter ahead (new lockdowns have already been announced in California and …

Keep reading with a 7-day free trial

Subscribe to Boardroom Governance Newsletter to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Evan Epstein
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share